Vertex Pharmaceuticals Inc / Ma
2013 Q4 - 2025 Q4 (27 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 174,884 | 0.2% | 385,751 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 154,534 | 0.2% | 394,582 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 177,029 | 0.2% | 397,640 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 193,193 | 0.2% | 398,483 | 3/31/2025 |
| 2024 Q4 | 3/18/2025 | 161,350 | 0.2% | 400,670 | 12/31/2024 |
| 2024 Q3 | 4/4/2025 | 191,835 | 0.2% | 412,477 | 9/30/2024 |
| 2024 Q2 | 4/8/2025 | 194,934 | 0.2% | 415,886 | 6/30/2024 |
| 2024 Q1 | 5/16/2024 | 174,294 | 0.2% | 416,962 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 168,729 | 0.2% | 414,680 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 142,188 | 0.2% | 408,893 | 9/30/2023 |
| 2023 Q2 | 8/21/2023 | 149,624 | 0.2% | 425,177 | 6/30/2023 |
| 2023 Q1 | 5/9/2023 | 136,468 | 0.2% | 433,137 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 126,201 | 0.2% | 437,015 | 12/31/2022 |
| 2022 Q3 | 11/21/2022 | 124,508 | 0.2% | 430,019 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 122,128 | 0.2% | 433,401 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 112,002 | 0.1% | 429,177 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 101,312 | 0.1% | 461,347 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 81,368 | 0.1% | 448,582 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 92,291 | 0.1% | 457,726 | 6/30/2021 |
| 2021 Q1 | 5/18/2021 | 104,558 | 0.1% | 486,564 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 114,968 | 0.2% | 486,450 | 12/31/2020 |
| 2020 Q3 | 11/17/2020 | 128,801 | 0.2% | 473,324 | 9/30/2020 |
| 2020 Q2 | 8/17/2020 | 136,094 | 0.2% | 468,787 | 6/30/2020 |
| 2020 Q1 | 5/13/2020 | 111,456 | 0.2% | 468,402 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 101,678 | 0.2% | 464,389 | 12/31/2019 |
| 2014 Q1 | 5/8/2014 | 29,951 | 0.1% | 423,512 | 3/31/2014 |
| 2013 Q4 | 2/10/2014 | 31,318 | 0.1% | 421,512 | 12/31/2013 |